1,535
Views
11
CrossRef citations to date
0
Altmetric
Neurology

Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data

, , , , &
Pages 515-525 | Accepted 24 Dec 2015, Published online: 18 Jan 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Debashis Biswas, Beverly Karabin & Debra Turner. (2019) Role of nurses and nurse practitioners in the recognition, diagnosis, and management of neurogenic orthostatic hypotension: a narrative review. International Journal of General Medicine 12, pages 173-184.
Read now
Alexander S. Wang & Steven A. Gunzler. (2019) Systematic review of the pharmacoeconomics of Parkinson disease medications. Expert Opinion on Pharmacotherapy 20:13, pages 1659-1670.
Read now
Santiago Pérez-Lloret, Cecilia Quarracino, Matilde Otero-Losada & Olivier Rascol. (2019) Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases. Expert Opinion on Pharmacotherapy 20:6, pages 635-645.
Read now
Clement François, Italo Biaggioni, Cyndya Shibao, Augustina Ogbonnaya, Huai-Che Shih, Eileen Farrelly, Adam Ziemann & Amy Duhig. (2017) Fall-related healthcare use and costs in neurogenic orthostatic hypotension with Parkinson’s disease. Journal of Medical Economics 20:5, pages 525-532.
Read now

Articles from other publishers (7)

Xiao-Zhong Jing, Xiang-Zhen Yuan, Xingguang Luo, Shu-Yun Zhang & Xiao-Ping Wang. (2023) An Update on Nondopaminergic Treatments for Motor and Non-motor Symptoms of Parkinson’s Disease. Current Neuropharmacology 21:8, pages 1806-1826.
Crossref
Evan L. Reynolds, Gary GallagherChloe E. HillMousumi BanerjeeAristotle ManteGregory J. EsperBrian C. Callaghan. (2023) Costs and Utilization of New-to-Market Neurologic Medications. Neurology 100:9.
Crossref
Natalie E Allen, Colleen G Canning, Lorena Rosa S Almeida, Bastiaan R Bloem, Samyra HJ Keus, Niklas Löfgren, Alice Nieuwboer, Geert SAF Verheyden, Tiê P Yamato & Catherine Sherrington. (2022) Interventions for preventing falls in Parkinson's disease. Cochrane Database of Systematic Reviews 2022:8.
Crossref
Carlo Federici & Leandro Pecchia. (2021) Early health technology assessment using the MAFEIP tool. A case study on a wearable device for fall prediction in elderly patients. Health and Technology 11:5, pages 995-1002.
Crossref
Paulina Gonzalez-Latapi, Suvorit Subhas Bhowmick, Gerard Saranza & Susan H. Fox. (2020) Non-Dopaminergic Treatments for Motor Control in Parkinson’s Disease: An Update. CNS Drugs 34:10, pages 1025-1044.
Crossref
Nafsika Afentou, Johan Jarl, Ulf‐G Gerdtham & Sanjib Saha. (2019) Economic Evaluation of Interventions in Parkinson's Disease: A Systematic Literature Review. Movement Disorders Clinical Practice 6:4, pages 282-290.
Crossref
Alfonso Fasano, Colleen G. Canning, Jeffrey M. Hausdorff, Sue Lord & Lynn Rochester. (2017) Falls in Parkinson's disease: A complex and evolving picture. Movement Disorders 32:11, pages 1524-1536.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.